North Dallas Bank & Trust Co. Invests $1.33 Million in UnitedHealth Group Incorporated $UNH

North Dallas Bank & Trust Co. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,261 shares of the healthcare conglomerate’s stock, valued at approximately $1,329,000. UnitedHealth Group makes up about 1.0% of North Dallas Bank & Trust Co.’s portfolio, making the stock its 29th biggest position.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 7.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,889 shares of the healthcare conglomerate’s stock worth $2,037,000 after acquiring an additional 283 shares during the last quarter. Tocqueville Asset Management L.P. boosted its position in UnitedHealth Group by 453.4% during the first quarter. Tocqueville Asset Management L.P. now owns 132,198 shares of the healthcare conglomerate’s stock valued at $69,238,000 after purchasing an additional 108,309 shares during the last quarter. Finally, Boston Family Office LLC increased its position in UnitedHealth Group by 12.5% in the 1st quarter. Boston Family Office LLC now owns 5,805 shares of the healthcare conglomerate’s stock worth $3,040,000 after purchasing an additional 647 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on UNH. Morgan Stanley increased their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target on the stock. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Finally, Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $385.54.

UnitedHealth Group Trading Up 1.5%

UnitedHealth Group stock opened at $341.83 on Friday. The business’s 50-day simple moving average is $339.84 and its 200-day simple moving average is $317.07. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The firm has a market capitalization of $309.65 billion, a PE ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the firm posted $7.15 EPS. The company’s revenue was up 12.2% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.